|Bid||46.11 x 900|
|Ask||46.37 x 1400|
|Day's Range||45.96 - 47.37|
|52 Week Range||23.41 - 49.49|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 15, 2021 - Nov 19, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||52.75|
SOMERSET, N.J., September 22, 2021--Legend Biotech will host its first Research & Development Day on Monday, October 18, commencing at 10:00 a.m. (Eastern Time), at Andaz 5th Avenue.
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
SOMERSET, N.J., September 13, 2021--Legend Biotech has announced the start of a Phase 1 clinical trial in the US for an investigational treatment for relapsed/refractory T-cell lymphoma.